In T2DM, the deterioration of insulin secretion and hypoinsulinemia may develop during the progression of the disease due to treatment failure with diet or oral hypoglycemic agents and poor glycemic control [53]. The gene discussed is INS; the disease is type 2 diabetes mellitus.